Other · developed by Pulmatrix
PUR0200 is a dry powder inhalation product.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT02671825 | Phase 1 | Healthy | Completed | PULM |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Healthy
Updated Oct 25, 2026. Something wrong or missing? Report it on the PULM page.
See PULM's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
PULM catalysts and pipeline →